105 related articles for article (PubMed ID: 16513680)
1. Peroxisome proliferator-activated receptor (PPAR) gamma gene polymorphisms and colorectal cancer risk among Chinese in Singapore.
Koh WP; Yuan JM; Van Den Berg D; Ingles SA; Yu MC
Carcinogenesis; 2006 Sep; 27(9):1797-802. PubMed ID: 16513680
[TBL] [Abstract][Full Text] [Related]
2. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
3. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
Jiang J; Gajalakshmi V; Wang J; Kuriki K; Suzuki S; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
Cancer Sci; 2005 Aug; 96(8):507-12. PubMed ID: 16108832
[TBL] [Abstract][Full Text] [Related]
4. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.
Wei Z; Han G; Bai X
Med Sci Monit; 2015 Jun; 21():1611-6. PubMed ID: 26049557
[TBL] [Abstract][Full Text] [Related]
5. Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan.
Wu MH; Chu CH; Chou YC; Chou WY; Yang T; Hsu GC; Yu CP; Yu JC; Sun CA
Breast Cancer Res Treat; 2011 Jun; 127(3):777-84. PubMed ID: 21140205
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.
Zhao J; Zhi Z; Song G; Wang J; Wang C; Ma H; Yu X; Sui A; Zhang H
Asian Pac J Cancer Prev; 2015; 16(6):2333-40. PubMed ID: 25824760
[TBL] [Abstract][Full Text] [Related]
7. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
[TBL] [Abstract][Full Text] [Related]
8. The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.
Gong Z; Xie D; Deng Z; Bostick RM; Muga SJ; Hurley TG; Hebert JR
Carcinogenesis; 2005 Mar; 26(3):579-85. PubMed ID: 15564289
[TBL] [Abstract][Full Text] [Related]
9. PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.
Vogel U; Segel S; Dethlefsen C; Tjønneland A; Saber AT; Wallin H; Jensen MK; Schmidt EB; Andersen PS; Overvad K
BMC Med Genet; 2009 Jun; 10():52. PubMed ID: 19500413
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.
Lu YL; Li GL; Huang HL; Zhong J; Dai LC
World J Gastroenterol; 2010 May; 16(17):2170-5. PubMed ID: 20440859
[TBL] [Abstract][Full Text] [Related]
11. PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study.
García-Broncano P; Berenguer J; Fernández-Rodríguez A; Pineda-Tenor D; Jiménez-Sousa MÁ; García-Alvarez M; Miralles P; Aldámiz-Echevarria T; López JC; Micheloud D; Resino S
J Transl Med; 2014 Aug; 12():235. PubMed ID: 25159899
[TBL] [Abstract][Full Text] [Related]
12. Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.
Kuriki K; Hirose K; Matsuo K; Wakai K; Ito H; Kanemitsu Y; Hirai T; Kato T; Hamajima N; Takezaki T; Suzuki T; Saito T; Tanaka R; Tajima K
Cancer Sci; 2006 Nov; 97(11):1226-35. PubMed ID: 16965392
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
[TBL] [Abstract][Full Text] [Related]
14. Impact of Interaction Between PPAR Alpha and PPAR Gamma on Breast Cancer Risk in the Chinese Han Population.
Lianggeng X; Baiwu L; Maoshu B; Jiming L; Youshan L
Clin Breast Cancer; 2017 Aug; 17(5):336-340. PubMed ID: 28669518
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of peroxisome proliferator-activated receptor-γ gene polymorphisms with sepsis.
Liu Y; Wan W; Fang F; Guo L; Zhao Y; Zhang X; Huang F
J Clin Lab Anal; 2018 May; 32(4):e22340. PubMed ID: 29055064
[TBL] [Abstract][Full Text] [Related]
16. [Meta-analysis of the association between PPARγ2 gene Pro12Ala polymorphism and obesity in Chinese population].
Li M; Wang Y; Ayiguli A; Haiqiemuhan A; Liu Z
Wei Sheng Yan Jiu; 2021 Mar; 50(2):315-319. PubMed ID: 33985643
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor γ2 Pro12Ala (rs1801282) polymorphism and breast cancer susceptibility: a meta-analysis.
Mao Q; Guo H; Gao L; Wang H; Ma X
Mol Med Rep; 2013 Dec; 8(6):1773-8. PubMed ID: 24141935
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferators-activated receptor gamma polymorphisms and colorectal cancer risk.
Liang X; Fan X; Tan K; Zhang L; Jian L; Yu L
J Cancer Res Ther; 2018 Jun; 14(Supplement):S306-S310. PubMed ID: 29970681
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
[TBL] [Abstract][Full Text] [Related]
20. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility.
Kurnaz-Gomleksiz O; Torun BC; Isbir T; Bulut T; Sokucu N; Yilmaz-Aydogan H; Canbay E
In Vivo; 2022; 36(4):1911-1915. PubMed ID: 35738614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
